{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:13:02Z","timestamp":1790266382470,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P3-0308"],"award-info":[{"award-number":["P3-0308"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0420"],"award-info":[{"award-number":["P1-0420"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Slovenian Research and Innovation Agency","doi-asserted-by":"publisher","award":["P1-0170"],"award-info":[{"award-number":["P1-0170"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Plus"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.athplu.2026.100563","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:29:07Z","timestamp":1774546147000},"page":"100563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Proprotein convertase subtilisin\/kexin type 9\u2013CC-motif chemokine ligand 2 interactions link lipoprotein(a) composition to intermediate monocyte inflammation in coronary artery disease"],"prefix":"10.1016","volume":"65","author":[{"given":"Sabina","family":"Ugov\u0161ek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreja","family":"Rehberger Likozar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Levstek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Trebu\u0161ak Podkraj\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janja","family":"Zupan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frieda","family":"Marka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Trimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Brekalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Speidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Hohensinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9907-3522","authenticated-orcid":false,"given":"Miran","family":"\u0160ebe\u0161tjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athplu.2026.100563_bib1","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2026.100563_bib2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3389\/fphar.2019.00666","article-title":"Monocytes, macrophages, and metabolic disease in atherosclerosis","volume":"10","author":"Flynn","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.athplu.2026.100563_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.atherosclerosis.2010.05.004","article-title":"Association of monocyte subsets with vulnerability characteristics of coronary plaques as assessed by 64-slice multidetector computed tomography in patients with stable angina pectoris","volume":"212","author":"Kashiwagi","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2026.100563_bib4","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/j.jacc.2012.07.019","article-title":"CD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiography","volume":"60","author":"Rogacev","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.athplu.2026.100563_bib5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1160\/TH04-02-0095","article-title":"CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels","volume":"92","author":"Schlitt","year":"2004","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.athplu.2026.100563_bib6","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cvr\/cvv147","article-title":"Monocyte trafficking across the vessel wall","volume":"107","author":"Gerhardt","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.athplu.2026.100563_bib7","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","article-title":"Targeting the CCL2-CCR2 axis for atheroprotection","volume":"43","author":"Georgakis","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.athplu.2026.100563_bib8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/01.RES.0000146672.10582.17","article-title":"Chemokines in the pathogenesis of vascular disease","volume":"95","author":"Charo","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.athplu.2026.100563_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0022-2275(20)33509-4","article-title":"Expression of the monocyte chemoattractant protein-1 receptor CCR2 is increased in hypercholesterolemia. Differential effects of plasma lipoproteins on monocyte function","volume":"40","author":"Han","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.athplu.2026.100563_bib10","first-page":"1","article-title":"Lipoprotein(A)\u2014the crossroads of atherosclerosis, atherothrombosis and inflammation","volume":"12","author":"Ugov\u0161ek","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.athplu.2026.100563_bib11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacl.2015.04.005","article-title":"Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a)","volume":"9","author":"Krychtiuk","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.athplu.2026.100563_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/cvr\/cvx224","article-title":"CCR2 expression on circulating monocytes is associated with arterial wall inflammation assessed by 18F-FDG PET\/CT in patients at risk for cardiovascular disease","volume":"114","author":"Verweij","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.athplu.2026.100563_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032978","article-title":"Two-week interruption of Statin therapy results in an exaggerated inflammatory Monocyte phenotype in young patients with myocardial infarction without standard modifiable risk factors","volume":"13","author":"Mol","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.athplu.2026.100563_bib14","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/eurheartj\/ehx002","article-title":"PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia","volume":"38","author":"Bernelot Moens","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.athplu.2026.100563_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.athplu.2022.07.001","article-title":"Smoking and diabetes attenuate beneficial effects of PSCK9 inhibitors on arterial wall properties in patients with very high lipoprotein (a) levels","volume":"50","author":"Rehberger Likozar","year":"2022","journal-title":"Atherosclerosis Plus"},{"key":"10.1016\/j.athplu.2026.100563_bib16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.athplu.2026.100563_bib17","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.3390\/ijms23031881","article-title":"Quantitative and functional assessment of the influence of routinely used cryopreservation media on mononuclear leukocytes for medical research","volume":"23","author":"Haider","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.athplu.2026.100563_bib18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-8587(17)30088-8","article-title":"Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis","volume":"5","author":"Saleheen","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.athplu.2026.100563_bib19","article-title":"Effects of proprotein convertase subtilisin-kexin type 9 inhibitors on inflammatory and hemostatic parameters in post myocardial infarction patients","volume":"963","author":"Rehberger","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.athplu.2026.100563_bib20","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"FOURIER steering committee and investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.athplu.2026.100563_bib21","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"ODYSSEY OUTCOMES committees and investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.athplu.2026.100563_bib22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.atherosclerosis.2014.10.015","article-title":"Small high-density lipoprotein is associated with monocyte subsets in stable coronary artery disease","volume":"237","author":"Krychtiuk","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2026.100563_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123367","article-title":"Association of small dense LDL serum levels and circulating monocyte subsets in stable coronary artery disease","volume":"10","author":"Krychtiuk","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.athplu.2026.100563_bib24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3390\/ph15070802","article-title":"Impact of PCSK9 inhibition on proinflammatory cytokines and matrix metalloproteinases release in patients with mixed hyperlipidemia and vulnerable atherosclerotic plaque","volume":"15","author":"Basiak","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.athplu.2026.100563_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5551\/jat.49791","article-title":"Relationship between circulating inflammatory monocytes and cardiovascular disease measures of carotid intimal thickness","volume":"27","author":"SahBandar","year":"2020","journal-title":"J Atherosclerosis Thromb"},{"key":"10.1016\/j.athplu.2026.100563_bib26","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/07853890.2020.1775287","article-title":"Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options","volume":"52","author":"Rehberger Likozar","year":"2020","journal-title":"Ann Med"},{"key":"10.1016\/j.athplu.2026.100563_bib27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12170-025-00759-8","article-title":"Current clinical trials for treating elevated lipoprotein(a)","volume":"19","author":"De Los Reyes","year":"2025","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"10.1016\/j.athplu.2026.100563_bib28","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jacl.2021.02.005","article-title":"Circulating levels of proprotein convertase subtilisin\/kexin type 9 (PCSK9) are associated with monocyte subsets in patients with stable coronary artery disease","volume":"15","author":"Krychtiuk","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.athplu.2026.100563_bib29","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCULATIONAHA.115.018531","article-title":"Circulating proprotein convertase subtilisin\/kexin type 9 (PCSK9) predicts future risk of cardiovascular events independently of established risk factors","volume":"133","author":"Leander","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2026.100563_bib30","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11883-016-0604-3","article-title":"Statins and their effect on PCSK9\u2014Impact and clinical relevance","volume":"18","author":"Taylor","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.athplu.2026.100563_bib31","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/dom.12536","article-title":"Effect of statin therapy on plasma proprotein convertase subtilisin kexin 9 (PCSK9) concentrations: a systematic review and meta-analysis of clinical trials","volume":"17","author":"Sahebkar","year":"2015","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.athplu.2026.100563_bib32","article-title":"Role of the CCL2-CCR2 axis in cardiovascular disease: pathogenesis and clinical implications","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.athplu.2026.100563_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/CIRCULATIONAHA.118.035905","article-title":"Genetically determined levels of circulating cytokines and risk of stroke","volume":"139","author":"Georgakis","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.athplu.2026.100563_bib34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bbrc.2017.02.085","article-title":"PCSK9 regulates the chemokine receptor CCR2 on monocytes","volume":"485","author":"Grune","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.athplu.2026.100563_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2478\/jtim-2023-0136","article-title":"Impacts of cryopreservation on phenotype and functionality of mononuclear cells in peripheral blood and ascites","volume":"12","author":"Zhang","year":"2024","journal-title":"J Transl Int Med"},{"key":"10.1016\/j.athplu.2026.100563_bib36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.ATV.0000254674.47693.e8","article-title":"Cholesterol enrichment of human monocyte\/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles","volume":"27","author":"Liu","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.athplu.2026.100563_bib37","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"ESC scientific document group. 2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"}],"container-title":["Atherosclerosis Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089526000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089526000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:50:08Z","timestamp":1790265008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667089526000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S2667089526000179"],"URL":"https:\/\/doi.org\/10.1016\/j.athplu.2026.100563","relation":{},"ISSN":["2667-0895"],"issn-type":[{"value":"2667-0895","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proprotein convertase subtilisin\/kexin type 9\u2013CC-motif chemokine ligand 2 interactions link lipoprotein(a) composition to intermediate monocyte inflammation in coronary artery disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athplu.2026.100563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100563"}}